Ahn-Gook Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	49,560	38,949	15,844	28,991	18,219	13,650
Short-Term Investments	2,300	2,300	2,300	5,050	11,050	7,496
Trading Asset Securities	14,476	12,802	11,594	1,405	9,173	26,314
Cash & Short-Term Investments	66,335	54,050	29,738	35,446	38,442	47,460
Cash Growth	108.94%	81.75%	-16.10%	-7.79%	-19.00%	-5.59%
Accounts Receivable	33,979	28,598	58,722	62,132	54,917	43,059
Other Receivables	109.36	702.89	133.27	461.03	519.21	817.96
Receivables	34,248	29,460	59,015	62,753	55,597	44,159
Inventory	47,343	51,367	44,672	35,718	26,594	23,891
Prepaid Expenses	408.83	233.86	223.64	130.74	75.04	90.25
Other Current Assets	2,720	1,653	1,123	1,368	1,302	683.49
Total Current Assets	151,056	136,765	134,772	135,416	122,010	116,285
Property, Plant & Equipment	123,481	122,986	120,069	73,036	70,771	70,911
Long-Term Investments	25,821	25,182	28,043	22,927	23,037	26,872
Goodwill	2,990	2,990	-	-	-	-
Other Intangible Assets	5,365	5,565	3,901	4,287	4,087	3,874
Long-Term Deferred Tax Assets	3,831	3,645	2,086	1,722	2,816	843.94
Other Long-Term Assets	13,620	13,819	13,664	1,208	1,193	1,171
Total Assets	326,163	310,953	302,535	238,598	223,912	219,956
Accounts Payable	12,683	13,796	10,265	15,208	12,643	10,141
Accrued Expenses	14,102	14,246	12,060	10,619	8,974	6,141
Short-Term Debt	27,300	22,300	27,300	17,300	19,450	19,600
Current Portion of Long-Term Debt	66.6	66.6	-	-	8.25	60.93
Current Portion of Leases	275.42	264.33	197.36	259.14	336.51	296.49
Current Income Taxes Payable	3,408	-	3,652	238.13	1,369	383.15
Current Unearned Revenue	-	-	-	-	0.78	18.55
Other Current Liabilities	35,499	32,251	23,585	34,619	18,717	15,572
Total Current Liabilities	93,333	82,923	77,059	78,242	61,498	52,212
Long-Term Debt	50,100	50,117	50,000	-	-	8.25
Long-Term Leases	316.56	327.28	226.52	120.27	210.13	225.69
Pension & Post-Retirement Benefits	9,027	8,736	9,023	8,049	7,130	13,913
Long-Term Deferred Tax Liabilities	73.37	75.25	-	-	-	-
Other Long-Term Liabilities	2,504	2,485	1,483	520.06	402.69	316.44
Total Liabilities	155,354	144,663	137,792	86,932	69,241	66,675
Common Stock	6,521	6,521	6,521	6,521	6,521	6,521
Additional Paid-In Capital	8,331	8,331	15,531	15,531	15,531	15,531
Retained Earnings	159,776	154,601	145,070	131,553	133,487	127,754
Treasury Stock	-4,941	-4,941	-4,941	-4,941	-4,941	-4,387
Comprehensive Income & Other	182.66	862.29	3,494	3,422	4,199	8,001
Total Common Equity	169,870	165,375	165,676	152,086	154,798	153,421
Minority Interest	938.34	914.47	-932.34	-420.65	-126.44	-140.14
Shareholders' Equity	170,809	166,289	164,743	151,666	154,671	153,281
Total Liabilities & Equity	326,163	310,953	302,535	238,598	223,912	219,956
Total Debt	78,058	73,075	77,724	17,679	20,005	20,191
Net Cash (Debt)	-11,723	-19,024	-47,986	17,767	18,437	27,269
Net Cash Growth	-	-	-	-3.63%	-32.39%	-7.45%
Net Cash Per Share	-1031.95	-1673.90	-4221.58	1563.26	1620.25	2380.83
Filing Date Shares Outstanding	11.36	11.37	11.37	11.37	11.37	11.41
Total Common Shares Outstanding	11.36	11.37	11.37	11.37	11.31	11.41
Working Capital	57,723	53,842	57,713	57,174	60,511	64,072
Book Value Per Share	14951.61	14550.79	14577.25	13381.56	13683.36	13441.11
Tangible Book Value	161,516	156,821	161,774	147,799	150,711	149,547
Tangible Book Value Per Share	14216.26	13798.11	14233.98	13004.33	13322.13	13101.72
Land	36,756	36,756	36,756	19,501	19,501	19,501
Buildings	77,522	77,522	77,096	34,393	19,510	34,222
Machinery	48,877	47,493	42,522	34,066	29,974	33,184
Construction In Progress	6,883	5,891	830.04	24,210	22,712	21,973